Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Citius Pharmaceuticals Inc (NQ: CTXR ) 0.5163 -0.0237 (-4.39%) Streaming Delayed Price Updated: 4:00 PM EDT, Sep 25, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Citius Pharmaceuticals Inc < Previous 1 2 3 4 Next > The Daily Biotech Pulse: Sanofi, Translate Bio Start Early Stage Seasonal Flu Vaccine Study, Dr. Reddy's Launches Generic Vascepa, Halozyme Strikes Licensing Deal June 22, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 21) Agios Pharmaceuticals, Inc... Via Benzinga 48 Biggest Movers From Yesterday June 22, 2021 Gainers Lydall, Inc. (NYSE: LDL) shares jumped 85.4% to close at $61.72 on Monday after the company agreed to be acquired by Unifrax for $61.10 per share. New Concept Energy,... Via Benzinga Are Reddit Stocks Buyer Beware Or "Buyer Be There"? June 21, 2021 Reddit is not only coined Via Talk Markets 12 Health Care Stocks Moving In Monday's Intraday Session June 21, 2021 Gainers Anavex Life Sciences (NASDAQ:AVXL) shares moved upwards by 17.07% to $25.92 during Monday's regular session. Anavex Life Sciences's stock is trading at a... Via Benzinga Stocks That Hit 52-Week Highs On Friday June 18, 2021 Friday's morning session saw 39 companies set new 52-week highs. Areas of Significance: The largest company by market cap to set a new 52-week high was NVIDIA (... Via Benzinga Stocks That Hit 52-Week Highs On Monday June 21, 2021 Monday's morning session saw 49 companies set new 52-week highs. Intriguing Points: The largest company by market cap to hit a new 52-week high was Shopify (... Via Benzinga The Daily Biotech Pulse: Orphazyme Falters At FDA, Athira's CEO Placed On Temporary Leave, 5 IPOs June 18, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 17) 10x Genomics, Inc. (NASDAQ... Via Benzinga Exposures Product Safety Stocks That Hit 52-Week Highs On Thursday June 17, 2021 This morning 94 companies set new 52-week highs. Things to Consider: NVIDIA (NASDAQ:NVDA) was the largest firm by market cap to set a new 52-week high. Deswell Industries... Via Benzinga The Daily Biotech Pulse: Biogen Faces Another Clinical Setback, CureVac's COVID-19 Vaccine Study Fails, Moment Of Reckoning For Orphazyme June 17, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 16) Alexion Pharmaceuticals,... Via Benzinga Exposures COVID-19 Top 3 Penny Stocks to Buy Right Now for Your 2021 Summer Watchlist June 16, 2021 Best Penny Stocks to Watch in Summer 2021 With Summer upon us, which penny stocks are investors buying right now? Well, there are quite a few answers to this question. The first... Via Benzinga The Daily Biotech Pulse: Regeneron COVID-19 Antibody Cocktail Data, FDA Nod For Mallinckrodt, Molecular Partners IPO June 16, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 15) Apellis Pharmaceuticals,... Via Benzinga Exposures COVID-19 Product Safety 44 Biggest Movers From Yesterday June 16, 2021 Gainers Alzamend Neuro, Inc. (NASDAQ: ALZN) shares jumped 170% to close at $13.50 on Tuesday after the company priced its IPO at $5 per share. Alfi, Inc. (NASDAQ: ALF) shares... Via Benzinga Topics Initial Public Offering Exposures Securities Market 12 Health Care Stocks Moving In Tuesday's Intraday Session June 15, 2021 Gainers Clearside Biomedical (NASDAQ:CLSD) stock moved upwards by 26.21% to $3.81 during Tuesday's regular session. As of 12:30 EST, this security is trading at a... Via Benzinga Citius Pharma Plans Interim Analysis for Mino-Lok By End of June June 08, 2021 Citius Pharmaceuticals Inc (NASDAQ: CTXR) announced that the subsequent planned interim analysis for its Phase 3 trial of Mino-Lok for catheter-related bloodstream... Via Benzinga EXCLUSIVE: Citius Pharmaceuticals CEO Myron Holubiak Talks Company Advantages May 13, 2021 Myron Holubiak, president and CEO of Citius Pharmaceuticals Inc (NASDAQ: CTXR), appeared Thursday at Benzinga's Global Small Cap Conference for an... Via Benzinga Biotechs Zero in on Growing Ovarian Cancer Market as Pivotal Trials Advance Through Regulatory Agencies May 03, 2021 Via FinancialNewsMedia Topics Death Exposures Death 12 Health Care Stocks Moving In Tuesday's Pre-Market Session April 27, 2021 Gainers Aldeyra Therapeutics (NASDAQ:ALDX) stock moved upwards by 25.29% to $13.92 during Tuesday's pre-market session. The company's market cap stands at $661.8... Via Benzinga Citius Thrives in 2021 with Critical Care Solutions for ARDS Associated with COVID-19 April 19, 2021 The following article is sponsored by Citius Pharmaceuticals, Inc. The information contained in this article in no way represents investment advice or opinion on the part of... Via Benzinga 12 Health Care Stocks Moving In Thursday's Pre-Market Session April 15, 2021 Gainers Assertio Holdings (NASDAQ:ASRT) stock increased by 19.41% to $0.62 during Thursday's pre-market session. The company's market cap stands at $107.3 million... Via Benzinga Exclusive: Citius Pharmaceuticals Exec Chairman On Product Pipeline, Potential $1B TAM April 08, 2021 Citius Pharmaceuticals Inc. (NASDAQ: CTXR) Executive Chairman Leonard Mazur told Benzinga CEO Jason Raznick Thursday that he's invested $26.5 million of his own money in the... Via Benzinga < Previous 1 2 3 4 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.